Rh mosaicism and aberrant MNSs antigen expression in a patient with chronic myelogenous leukemia.
This is, to our knowledge, the first report of combined Rh and MNSs antigen alteration in a leukemic patient. Red blood cells of a chronic myelogenous leukemia patient demonstrated mixed field reactions with anti-Rho (D) reagents in August 1980. Earlier tests indicated he was Rho (D) positive in 1967, but Rho (D) and Du negative from 1973 to 1980. Titration studies with anti-hr' (c) and anti-hr" (e) indicated depressed expression, and there was also very weak s expression. One hundred per cent of cells studied from 1967 to 1980 were Philadelphia chromosome (Ph1) positive. No abnormalities in chromosomes associated with the Rh or MNSs blood groups 1 and 4, respectively, were noted. Phenotypes from August 1980 through September 1981 revealed normalization of red blood cell antigen status with an increase of Rho (D) positive cells from 35% to 100%. Chromosomal studies in October, 1980 and June, 1981 revealed Ph1 mosaicism with 25 and 75% Ph1 negative cells, respectively. These findings suggest that normalization of previously altered red blood cell antigen expression may reflect resurgence of normal stem cell lines.
D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000097:blood*; D008951:MNSs Blood-Group System / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009030:Mosaicism; D010641:Phenotype; D012204:Rh-Hr Blood-Group System / Q000235:genetics*
D008951:MNSs Blood-Group System; D012204:Rh-Hr Blood-Group System